pharma · Asthma · Type 2 Diabetes
AstraZeneca
AstraZeneca clinical programs — 11 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Company details
- Status
- Public
- HQ
- 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridgeshire CB2 0AA, GB
- Employees
- 79,242
- Programs
- 129
- Drugs
- 77
- Patents
- 25
AstraZeneca projects
11 ClinicalTrials.gov programs sponsored by AstraZeneca.
AstraZeneca has 11 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
-
AZD0449
AstraZeneca
Asthma
1 trial -
AZD0530
AstraZeneca
Solid Tumor
1 trial -
AZD3514
AstraZeneca
Prostate Cancer
1 trial -
AZD6244
AstraZeneca
Neoplasms,
1 trial -
AZD7762
AstraZeneca
Cancer
1 trial -
Benralizumab
AstraZeneca
Healthy Subjects
1 trial -
Capivasertib
AstraZeneca
Advanced Solid Tumours
1 trial -
Ceralasertib
AstraZeneca
Advanced Solid Malignancies
1 trial -
Cisplatin
AstraZeneca
Inoperable Locally Advanced or Metastatic Biliary Tract Cancer
1 trial -
Drug-AZD8931
AstraZeneca
Breast Neoplasm
1 trial -
Sodium Zirconium Cyclosilicate (ZS)
AstraZeneca
Hyperkalemia
1 trial
Frequently asked questions
How many clinical projects does AstraZeneca have?
11 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.